A Phase I/Randomized Phase II Study of MLN0128 vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I/Randomized Phase II Study of MLN0128 vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma

Type of Cancer
Skin and Soft Tissue
Locations
Hackensack
Sponsor
Alliance
Protocol Number
A091304
Cancer Diagnosis
To Learn More Call
201-510-0910